טוען…

Trevo · Smart job discovery for the Israeli tech market

InspireMD

Healthtech

Tel Aviv - Jaffa

HiringSteadyAttractivenessFHealth (proxy)~Fas of 6 Jun

Open jobs in Israel

Posting timing (day/hour) is available only when there are at least 5 jobs with a real publish stamp spread across 3 distinct days. This company's source doesn't expose post times, or there isn't enough data yet — showing what we know for sure: how many jobs are open, in which domains, and at which seniority levels.

Showing: Israel. Click another pill to switch.

Open now

Total active openings across all sites

Δ 28-day

Opens minus closes in the last 28 days

Δ 90-day

Opens minus closes in the last 90 days

posting velocity //

Opens vs closes per day

company intel · ai-generated

Company intel & deep analysis

Updated 1d ago

Product
Regulatory

Snapshot

InspireMD is a medical device company focused on developing and commercializing stents with a protective mesh technology for vascular disease treatment. The company is listed on NYSE American under the ticker NSPR, with its registered headquarters in Boston, Massachusetts, and R&D activity historically based in Tel Aviv.

Core Activity

InspireMD's central product line is built around MicroNet technology — a tightly woven mesh sleeve that encases a stent and is designed to trap plaque debris during vessel dilation, reducing the risk of embolic stroke. The primary clinical application is carotid artery stenting (CAS), where embolic complications are the dominant procedural risk.

key people & leadership

Key people & leadership

1 key people, sourced from public records — with a per-row confidence score.

Marvin Slosman

Chief Executive Officer

🟡Likely🔍 in

Verified 1d ago

Private company — not publicly traded.

No public financial filings (private company).

Funding rounds from the press — coming soon.

Based on 0 events over 90 days. Green days had more opens than closes, red vice-versa. The dark line is the 7-day rolling average.

role mix //

Role mix — current vs baseline

—

The green layer is the current share of active openings by role. The grey dashed layer is the 90-day baseline — gaps between them show where the company is shifting its hiring mix.

seniority pyramid //

Seniority pyramid

Seniority is not exposed by the source for this company.

Distribution of active openings by seniority. The 'unknown' row groups jobs from sources that don't expose seniority.

geography //

Geographic split

—

Active openings by region. Click a row to see jobs in that area.

time on market //

How long a job stays open

Median

—

25th pct

—

75th pct

—

Based on 0 closed jobs and 0 still open (right-censored). Curve is Kaplan-Meier; band is the 95% CI.

Window: 180 days back. Don't read the mean — the long tail biases it. Median and percentiles are the honest summary.

Republish rate

—

Fewer than 10 closures in the window — not enough to compute.

Products & Services

The flagship product is CGuard EPS, a carotid artery stent integrating the MicroNet embolic protection system. CGuard EPS received FDA approval in 2023 following the C-GUARDIANS pivotal clinical trial. The product had also been available in European markets in prior years under CE Mark.

Market Position

InspireMD operates in the carotid intervention market, where CAS competes primarily against carotid endarterectomy (open surgery) and other stent-based systems. The FDA clearance of CGuard EPS in 2023 was the company's most significant commercial milestone, opening access to the U.S. market.

Israel Presence

InspireMD has maintained R&D presence in Tel Aviv. Detailed current information on Israel headcount or the breakdown of functions there is not something I can confirm with sufficient certainty.

news feed

No recent news about this company.